VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10
VistaGen Therapeutics Receives FDA Fast Track Designation for Development of AV-101 as a Non-Opioid Treatment for Neuropathic Pain
VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals
Juggernaut Confirms District Scale Gold-Rich System on Big One Property Measuring 22 km2 with Assays up to 263.70 g/t AuEq that is Drill Ready, Golden Triangle, B.C.
